Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 6/20 | 0.39 |
| ▸ | EGFR | P00533 | 4/20 | 0.38 |
| ▸ | ABL1 | P00519 | 2/20 | 0.38 |
| ▸ | ABL2 | P42684 | 2/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.36 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.36 |
| ▸ | PRKDC | P78527 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 7/20 | 0.36 |
| ▸ | TEK | Q02763 | 6/20 | 0.36 |
| ▸ | LCK | P06239 | 3/20 | 0.36 |
| ▸ | EIF2AK3 | Q9NZJ5 | 1/20 | 0.34 |
| ▸ | NEK7 | Q8TDX7 | 2/20 | 0.33 |
| ▸ | CFTR | P13569 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20182291 | 0.92 | NTRK1 (0.38) | SRCPIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL20182197 | 0.90 | CFTR (0.43) | SRCEGFRABL1ABL2PIK3CD | |
| SCHEMBL20182204 | 0.89 | KDR (0.37) | SRCEGFRABL1ABL2PIK3CD | |
| SCHEMBL20181912 | 0.88 | SRC (0.41) | SRCEGFRABL1ABL2PIK3CD | |
| SCHEMBL20182248 | 0.85 | LRRK2 (0.34) | SRCEGFRABL1ABL2PIK3CD | |
| SCHEMBL20182198 | 0.85 | SRC (0.34) | SRCEGFRABL1ABL2PIK3CD | |
| SCHEMBL20182285 | 0.84 | CFTR (0.41) | SRCEGFRABL1ABL2PIK3CD | |
| SCHEMBL20181916 | 0.83 | CFTR (0.39) | SRCEGFRABL1ABL2KDR | |
| SCHEMBL20182194 | 0.83 | EIF2AK3 (0.36) | SRCEGFRABL1ABL2PIK3CD | |
| SCHEMBL20182227 | 0.82 | EGFR (0.36) | SRCEGFRABL1ABL2PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018094137-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) | 2018-05-24 | — | — | WO | disclosed |